Hearing loss has a huge impact on the quality of life for millions of people, and as the average age of the population increases, the need for curative life-changing therapies targeting hearing loss and inner ear disorders has never been more important.

The Inner Ear Disorders Therapeutics Summit is gathering the world’s leading biopharmaceutical companies and KOLs at the only industry-focused summit dedicated to the translation and clinical development of novel gene therapy, cell therapy and small molecule-based approaches to treat inner ear disorders, with the aim to progress the industry towards the first clinically approved therapy.

Join industry and academic experts to discuss the best preclinical modelling approaches for translative proof of concept data, identify the most appropriate biological endpoints and overcome the major challenges to develop safe, effective, and clinically viable inner ear disorder therapies to address the unmet medical need.

To know more about Inner Ear Disorders Therapeutics Summit please click here.